Published in Ann N Y Acad Sci on January 01, 1987
Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead. PLoS One (2011) 0.87
The protective effect of delta-aminolevulinic acid dehydratase 1-2 and 2-2 isozymes against blood lead with higher hematologic parameters. Environ Health Perspect (2004) 0.84
Lead-binding proteins: a review. J Toxicol (2011) 0.79
Blood lead levels, ALAD gene polymorphisms, and mortality. Epidemiology (2011) 0.78
Isolation and partial characterization of a cadmium-binding protein from the American oyster (Crassostrea virginica). Chem Biol Interact (1979) 1.43
TCDD-induced changes in rat liver microsomal enzymes. Environ Health Perspect (1973) 1.24
Ultrastructural and biochemical effects of prolonged oral arsenic exposure on liver mitochondria of rats. Environ Health Perspect (1977) 1.12
Occupational lead exposure, nephropathy, and renal cancer. Am J Ind Med (1980) 1.12
Arsine poisoning. N Engl J Med (1974) 1.09
Early cellular effects of circulating cadmium-thionein on kidney proximal tubules. Environ Health Perspect (1979) 1.07
Effects of arsenic on pyruvate dehydrogenase activation. Environ Health Perspect (1977) 1.06
Mercury uptake by renal lysosomes of rats ingesting methyl mercury hydroxide. Ultrastructural observations and energy dispersive x-ray analysis. Arch Pathol (1974) 1.05
The morphological effects of chronic cadmium administration on the renal vasculature of rats given low and normal calcium diets. Toxicol Appl Pharmacol (1975) 1.03
Mechanisms of nephrotoxicity from metal combinations: a review. Drug Chem Toxicol (2000) 1.00
High-affinity lead binding proteins in rat kidney cytosol mediate cell-free nuclear translocation of lead. J Pharmacol Exp Ther (1985) 0.99
Intracellular binding of lead in the kidney: the partial isolation and characterization of postmitochondrial lead binding components. Biochem Biophys Res Commun (1982) 0.96
Effects of lead on the heme biosynthetic pathway in rat kidney. Exp Mol Pathol (1985) 0.96
Purification and characterization studies of cadmium-binding proteins from the American oyster, Crassostrea virginica. Environ Health Perspect (1986) 0.95
Alteration in protein synthesis in primary cultures of rat kidney proximal tubule epithelial cells by exposure to gallium, indium, and arsenite. Toxicol Appl Pharmacol (1990) 0.95
Isolation and partial characterization of a high molecular weight Cd/Zn-binding protein from the kidney of the scallop Placopecten magellanicus: preliminary studies. Environ Health Perspect (1986) 0.95
The effects of chronic oral methyl mercury exposure on the lysosome system of rat kidney. Morphometric and biochemical studies. Lab Invest (1975) 0.95
Chronic low-level lead toxicity in the rat. III. An integrated assessment of long-term toxicity with special reference to the kidney. Toxicol Appl Pharmacol (1980) 0.95
Intracellular compartmentation of metals in aquatic organisms: roles in mechanisms of cell injury. Environ Health Perspect (1987) 0.95
In vivo X-ray fluorescence of lead in bone. Environ Res (1992) 0.94
Effects of chronic arsenic exposure on hematopoietic function in adult mammalian liver. Environ Health Perspect (1977) 0.94
The transplacental toxicity of methyl mercury to fetal rat liver mitochondria. Morphometric and biochemical studies. Lab Invest (1977) 0.94
The morphologic effects of dieldrin and methyl mercuric chloride on pars recta segments of rat kidney proximal tubules. Am J Pathol (1972) 0.93
Ultrastructural and biochemical changes in renal mitochondria during chronic oral methyl mercury exposure: the relationship to renal function. Exp Mol Pathol (1977) 0.93
Influence of metal ions on renal cytosolic lead-binding proteins and nuclear uptake of lead in the kidney. Biochem Pharmacol (1986) 0.93
The renal toxicity of cadmium metallothionein: morphometric and X-ray microanalytical studies. Toxicol Appl Pharmacol (1978) 0.92
Ruthenium red staining of rat glomerulus. Perfusion of ruthenium red into normal and nephrotic rat kidney. Histochemie (1970) 0.91
Mechanism of renal lead-binding protein reversal of delta-aminolevulinic acid dehydratase inhibition by lead. J Pharmacol Exp Ther (1985) 0.91
Bismuth localization within nuclear inclusions by x-ray microanalysis. Effects of accelerating voltage. J Histochem Cytochem (1975) 0.91
Studies on the action of porphyrinogenic trace metals on the activity of hepatic uroporphyrinogen decarboxylase. Biochem Biophys Res Commun (1981) 0.90
Concurrent exposure to lead, cadmium, and arsenic. Effects on toxicity and tissue metal concentrations in the rat. J Lab Clin Med (1981) 0.89
Alteration of hepatic microsomal structure and function by indium chloride. Ultrastructural, morphometric, and biochemical studies. Lab Invest (1983) 0.89
Ultrastructural evidence for nephropathy induced by long-term exposure tosmall amounts of methyl mercury. Science (1972) 0.89
Regulation of lead inhibition of delta-aminolevulinic acid dehydratase by a low molecular weight, high affinity renal lead-binding protein. J Pharmacol Exp Ther (1984) 0.89
Introduction and summary. International workshop on lead in bone: implications for dosimetry and toxicology. Environ Health Perspect (1991) 0.89
Factors influencing cadmium accumulation and its toxicity to marine organisms. Environ Health Perspect (1979) 0.88
High-affinity renal lead-binding proteins in environmentally-exposed humans. Chem Biol Interact (1998) 0.87
Renal porphyrinuria during chronic methyl mercury exposure. J Lab Clin Med (1977) 0.86
Lead inhibits secretion of osteonectin/SPARC without significantly altering collagen or Hsp47 production in osteoblast-like ROS 17/2.8 cells. Toxicol Appl Pharmacol (1992) 0.86
Cadmium-Metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding. J Pharmacol Exp Ther (1984) 0.86
Alteration of hepatocellular structure and function by thallium chloride: ultrastructural, morphometric, and biochemical studies. Toxicol Appl Pharmacol (1986) 0.86
Effects of concurrent administration of lead, cadmium, and arsenic in the rat. Environ Health Perspect (1977) 0.85
Effects of separate and combined chronic mercuric chloride and sodium selenate administration in rats: histological, ultrastructural, and x-ray microanalytical studies of liver and kidney. J Environ Pathol Toxicol (1979) 0.85
A low molecular weight lead-binding protein in brain attenuates lead inhibition of delta-aminolevulinic acid dehydratase: comparison with a renal lead-binding protein. J Pharmacol Exp Ther (1986) 0.85
Interactions among lead, cadmium, and arsenic in relation to porphyrin excretion patterns. Environ Health Perspect (1978) 0.85
Long-term turnover of cadmium metallothionein in liver and kidney following a single low dose of cadmium in rats. Biochim Biophys Acta (1981) 0.85
Preliminary purification and characterization studies of a low molecular weight, high affinity cytosolic lead-binding protein in rat brain. Biochem Biophys Res Commun (1989) 0.84
Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. IV. Current information on interpreting the health implications of tests. Ren Fail (1997) 0.84
Production of low molecular weight cadmium-binding proteins in rabbit lung following exposure to cadmium chloride. Biochem Pharmacol (1982) 0.84
Renal metabolism and toxicity of metallothionein. Dev Toxicol Environ Sci (1982) 0.83
Effects of the herbicide paraquat on the ultrastructure of mouse kidney. Am J Pathol (1971) 0.83
Ultrastructural changes in rat liver cells following a single oral dose of TCDD. Environ Health Perspect (1973) 0.82
Evidence for oxidative damage to red blood cells in mice induced by arsine gas. Toxicology (1990) 0.82
Observations on the preparation of epoxy embedded tissue samples for energy-dispersive x-ray analysis. Stain Technol (1973) 0.81
Lead-binding proteins in brain tissue of environmentally lead-exposed humans. Chem Biol Interact (1995) 0.81
Kidney zinc-thionein regulation of delta-aminolevulinic acid dehydratase inhibition by lead. Arch Biochem Biophys (1987) 0.81
Effect of intratracheal gallium arsenide administration on delta-aminolevulinic acid dehydratase in rats: relationship to urinary excretion of aminolevulinic acid. Toxicol Appl Pharmacol (1988) 0.81
The effects of acute and subacute sodium arsenite administration on carbohydrate metabolism. Toxicol Appl Pharmacol (1980) 0.81
Physiologically based pharmacokinetic (PBPK) tool kit for environmental pollutants--metals. SAR QSAR Environ Res (2010) 0.80
Metal alteration of uroporphyrinogen decarboxylase and coproporphyrinogen oxidase. Ann N Y Acad Sci (1987) 0.80
General subcellular effects of lead, mercury, cadmium, and arsenic. Environ Health Perspect (1978) 0.80
Arsine: absence of developmental toxicity in rats and mice. Fundam Appl Toxicol (1990) 0.80
Metal constitution of metallothionein influences inhibition of delta-aminolaevulinic acid dehydratase (porphobilinogen synthase) by lead. Biochem J (1987) 0.79
Altered regulation of mammalian hepatic heme biosynthesis and urinary porphyrin excretion during prolonged exposure to sodium arsenate. Toxicol Appl Pharmacol (1978) 0.79
The in vivo measurement of bone lead stores by 109Cd K X-ray fluorescence in a non-human primate (Macaca mulatta). Basic Life Sci (1993) 0.79
Studies on the mechanisms of thallium-mediated inhibition of hepatic mixed function oxidase activity. Correlation with inhibition of NADPH-cytochrome c (P-450) reductase. Biochem Pharmacol (1984) 0.79
Intracellular metabolism and effects of circulating cadmium-metallothionein in the kidney. Environ Health Perspect (1984) 0.79
The effects of prolonged oral arsenate exposure on liver mitochondria of mice: morphometric and biochemical studies. Toxicol Appl Pharmacol (1979) 0.79
Roles of metallothionein and related proteins in metal metabolism and toxicity: problems and perspectives. Environ Health Perspect (1986) 0.78
Alterations in the heme biosynthetic pathway from the III-V semiconductor metal, indium arsenide (InAs). Chem Biol Interact (1995) 0.78
Phenobarbital protection against methyl mercury neophrotoxicity. Proc Soc Exp Biol Med (1975) 0.77
Relationship between metal toxicity to subcellular systems and the carcinogenic response. Environ Health Perspect (1981) 0.77
Biochemical and ultrastructural changes in livers of cadmium-treated rats. Toxicol Appl Pharmacol (1977) 0.77
Effects of lead inclusion bodies on subcellular distribution of lead in rat kidney: the relationship to mitochondrial function. Exp Mol Pathol (1985) 0.77
Purification of invertebrate metallothioneins. Methods Enzymol (1991) 0.76
Correlation of human hepatotoxicants with hepatic damage in animals. Fundam Appl Toxicol (1983) 0.76
Altered regulation of hepatic heme metabolism by indium chloride. Toxicol Appl Pharmacol (1979) 0.76
Lead accumulation by rat renal brush border membrane vesicles. J Pharmacol Exp Ther (1984) 0.76
Studies of hepatic mitochondrial structure and function: morphometric and biochemical evaluation of in vivo perturbation by arsenate. Lab Invest (1979) 0.76
International conference on environmental arsenic: an overview. Environ Health Perspect (1977) 0.75
Cytotoxicity, zinc protection, and stress protein induction in rat proximal tubule cells exposed to cadmium chloride in primary cell culture. Ren Fail (1996) 0.75
Levels of toxic metals in marine organisms collected from Southern California coastal waters. Environ Health Perspect (1975) 0.75
Hematopoietic effects in mice exposed to arsine gas. Toxicol Appl Pharmacol (1989) 0.75
Role of ultrastructural techniques in understanding mechanisms of metal-induced nephrotoxicity. Fed Proc (1983) 0.75
In vivo 31P nuclear magnetic resonance studies of arsenite induced changes in hepatic phosphate levels. Biochem Biophys Res Commun (1986) 0.75
Selective inhibition of delta-aminolevulinic acid dehydratase by indium chloride in rat kidney: biochemical and ultrastructural studies. Exp Mol Pathol (1982) 0.75
Alteration of mitochondrial structure and heme biosynthetic parameters in liver and kidney cells by bismuth. Toxicol Appl Pharmacol (1987) 0.75
Geriatric bone lead metabolism in a female nonhuman primate population. Environ Res (1997) 0.75
Biological indicators of cadmium exposure. Methods Enzymol (1991) 0.75
Heavy metals in the environment. III: Overview. Environ Health Perspect (1975) 0.75
Pyruvate metabolism after in vivo exposure to oral arsenic. Chem Biol Interact (1978) 0.75
Health promotion services and evaluation in the workplace: pragmatic issues. AAOHN J (1995) 0.75
Interaction between arsenic and alloxan-induced diabetes--effects on rat urinary enzyme levels. Biochem Pharmacol (1981) 0.75
Tetrachlorodibenzo-p-dioxin induction of renal microsomal enzyme systems: ultrastructural effects on pars recta (S3) proximal tubule cells on the rat kidney. J Pharmacol Exp Ther (1977) 0.75
Activation of delta-aminolevulinic acid dehydratase following donation of zinc from kidney metallothionein. Experientia Suppl (1987) 0.75
International Conference on Environmental Cadmium: an overview. Environ Health Perspect (1979) 0.75
Adolescent health care concerns: challenges for nurses. ABNF J (1995) 0.75
Prenatal outreach: an approach to reduce infant mortality of African American infants. ABNF J (1995) 0.75
Combining traditional and RN students in a senior capstone experience: the student perspective. J Contin Educ Nurs (1999) 0.75
Alterations in renal heme biosynthesis during metal nephrotoxicity. Ann N Y Acad Sci (1987) 0.75